Unclaimed brand
SynAct Pharma is a clinical stage biotechnology company developing new innovative medicines with the ability to induce resolution of inflammation.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#10488F
Tory Blue
16, 72, 143
214, 80, 31
89, 50, 0, 44
#F7F5F4
Hint of Red
247, 245, 244
20, 16, 96
0, 1, 1, 3
#273144
Ebony Clay
39, 49, 68
219, 27, 21
43, 28, 0, 73
SynAct Pharma is a clinical stage biotechnology company that specializes in resolving inflammation through the targeted activation of the melanocortin system. Their goal is to provide immune balance and combat autoimmune and inflammatory diseases. Their extensive portfolio consists of both oral and injectable melanocortin agonists designed to induce anti-inflammatory and inflammation resolution activity.
The company's leading asset, resomelagon (AP1189), is currently undergoing evaluation in three Phase 2 clinical programs for rheumatoid arthritis, idiopathic membranous nephropathy, and virus-induced respiratory insufficiency. These programs aim to address conditions such as nephrotic syndrome and respiratory issues, including those related to COVID-19. In addition, SynAct recently completed the acquisition of TXP Pharma, expanding their melanocortin technology portfolio with complementary peptide agonists that can be tailored to a wide range of autoimmune and inflammatory conditions.
SynAct Pharma is dedicated to leveraging melanocortin biology to bring innovative solutions to patients suffering from inflammatory disorders
Company type
Public Company
Year founded
2013
Company size
2-10 employees
The SynAct Pharma name, logos and brand assets are trademarks of SynAct Pharma and its affiliates. Brandfetch isn't affiliated with or endorsed by SynAct Pharma. Their use is subject to SynAct Pharma's brand guidelines.
